Purchase Order HHSN272201500439P
- Not listed
- This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...
- This is a federal contract award to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $1,504.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is for Ozgene to maintain a small colony of mice for a 12-week period, including mating wild-type and...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,286 firm fixed-price delivery order is for additional mouse breeding services to support biomedical research, including the creation of gene knockout and gene knock-in mice. This award is part of a larger, on-going contractual...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, was issued to the prime contractor Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The $4,850.10 fixed price award is for a project titled "AMBIS 1736053 PROJECT NO. 1551.6 BREEDING TO GENERATE A...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
- This federal contract award, with the ID HHSN272201100215P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $9,138.50 firm-fixed-price purchase order contract, which has no set-aside designation, is for gene targeting vector design and creation, mouse embryonic stem cell...
- This is a delivery order worth $2,244 awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), and did not utilize a set-aside designation. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $8,576.00, is for the breeding of ONO HCF-1 conditional knockout mice for removal of FLPAMBIS. No set-aside designation was used for this award. Ozgene has received multiple prior federal contracts from NIH institutes and centers, including the National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Child Health and Human Development, to provide gene targeting vectors, mouse embryonic stem cell generation, blastocyst injection, and mouse backcrossing and phenotyping services in support of various biomedical research projects.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 3/10/15 |